Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HCVree: Grazoprevir/Elbasvir in HIV/HCV Coinfected MSM
NCT02785666Phase 3Completed
- Sponsor
- University of Zurich
- Start
- Jun 2016
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of grazoprevir in hepatitis C (HCV), sponsored by University of Zurich. Started Jun 2016; status: completed.
02
Drugs
grazoprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02785666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02785666.